DENVER, June 20, 2017 /PRNewswire/ -- MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"), a scientifically
Through a cooperative research and development agreement (CRADA) initiated in late 2015, MusclePharm and USAFSAM are sharing resources to develop and produce a specially formulated Air Force powder supplement containing essential electrolytes, vitamins, minerals and proteins.
Paul Falcone, senior research and development manager, and his team at the MusclePharm Sports Science Institute (MPSSI) are collaborating with Dr. Reginald O'Hara and his Exercise Physiology Research Team at USAFSAM, part of the Air Force Research Laboratory's 711th Human Performance Wing. The goal of the collaboration is to formulate a unique powder supplement for special tactics airmen that will enhance energy, performance and cognition during sustained operations missions in extreme conditions. The supplement will be used in the field via an operator's CamelBak® hydration system.
The powder supplement will be made available to the Exercise Physiology Research Team at USAFSAM for testing purposes. The formulas developed by MusclePharm and USAFSAM are designed to provide nutrients essential to joint tactical air controllers (JTACs), special operations airmen, and other warfighters who must operate in austere, physically demanding environments.
"We are honored to have the opportunity to support the men and women of the United States Air Force," said Ryan Drexler, CEO of MusclePharm. "MusclePharm is focused on science, innovation and efficacy, and ultimately providing the best product possible to the public. This partnership allows us to execute against this strategy and receive feedback in order to ensure that we are meeting the explicit needs of Air Force special tactics airmen, who often face extreme and challenging conditions."
"MusclePharm's high quality products, combined with their commitment to scientific research, made them a logical partner," said Dr. Reginald O'Hara. "Supplements are a critical source of nutrition for our men and women in combat and it is crucial to ensure they are using the optimal product when in the field, as well as during training. The Company's Sports Science Institute has provided us with a platform to test ingredients and refine the product to support maximum performance."
MusclePharm is one of the only sports nutrition companies with a scientific institute that tests ingredients and develops in-house research, as well as partners with prestigious organizations, universities and research institutions to ensure the efficacy of its products.
About MusclePharm Corporation
MusclePharm® is a scientifically-driven, performance lifestyle company that develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. Its portfolio of recognized brands includes MusclePharm® Sport Series, Black Label and Core Series, and FitMiss™, which are available in more than 120 countries and over 50,000 retail outlets worldwide. The clinically-proven supplements are developed through a six-stage research process utilizing the expertise of leading nutritional scientists, doctors, and universities. MusclePharm is the innovator of the sports nutrition industry. For more information, visit http://www.musclepharm.com. To sign up to receive MusclePharm news via email, please visit http://ir.musclepharmcorp.com/email-alerts.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects", "anticipates", "intends", "estimates", "plans", "potential", "possible", "probable", "believes", "seeks", "may", "will", "should", "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015, the Company's Quarter Reports on Form 10-Q and other filings submitted by the Company to the Securities and Exchange Commission, copies of which may be obtained from the SEC's website at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/musclepharm-partners-with-united-states-air-force-school-of-aerospace-medicine-300476482.html
SOURCE MusclePharm Corporation
Subscribe to our Free Newsletters!
Malaria is a dangerous disease with lethal consequences that requires protective measures for ...
Merkel cell carcinoma is a rare and a highly aggressive primary skin cancer that grows rapidly and ...
Vitrectomy is a surgical procedure performed to remove a part or whole of the vitreous humor ...View All